3-Phenoxyazetidin-1-Yl-Heteroaryl Pyrrolidine Derivatives And The Use Thereof As Medicament - EP4402138
The patent EP4402138 was granted to Boehringer Ingelheim on Aug 27, 2025. The application was originally filed on Sep 9, 2022. The patent is currently recorded with a legal status of "Granted".
EP4402138
- Filing Date
- Sep 9, 2022
- Status
- Granted
- Grant Date
- Aug 27, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents